Literature DB >> 11672574

Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs.

T Noto1, H Inoue, H Mochida, K Kikkawa.   

Abstract

We studied the role of adenosine and P2 receptors in the pelvic nerve stimulation-induced penile tumescence in anesthetized dogs. A local intracavernous injection of adenosine induced the tumescence, which was abolished by intracavernous 8-(p-sulfophenyl)theophylline (8-SPT), an unspecific adenosine receptor antagonist, and by 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-yl amino]ethyl)phenol (ZM241385), an adenosine A(2A) receptor antagonist. ATP also induced the tumescence, which was diminished by 8-SPT, but not by reactive blue-2, a P2 receptor antagonist. Neither intracavernous beta, gamma-meATP nor ADP(beta)S, P2X and P2Y receptor agonists, induced tumescence. N(G)-nitro-L-arginine (L-NAME), a nitric oxide synthase inhibitor, and T-1032, a phosphodiesterase type V inhibitor, had no effects on the tumescence induced by adenosine. 8-SPT and reactive blue-2 had no effects on the tumescence induced by pelvic nerve stimulation. These results show that although exogenous adenosine and ATP induce tumescence, neither the adenosine nor the P2 receptor is involved in the tumescence induced by pelvic nerve stimulation in anesthetized dogs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672574     DOI: 10.1016/s0014-2999(01)01167-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 2.  Role of adenosine signaling in penile erection and erectile disorders.

Authors:  Prasad V Phatarpekar; Jiaming Wen; Yang Xia
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

3.  A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation.

Authors:  Jiaming Wen; Almut Grenz; Yujin Zhang; Yingbo Dai; Rodney E Kellems; Michael R Blackburn; Holger K Eltzschig; Yang Xia
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

4.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

Review 5.  Adenosine signaling in normal and sickle erythrocytes and beyond.

Authors:  Yujin Zhang; Yang Xia
Journal:  Microbes Infect       Date:  2012-05-23       Impact factor: 2.700

6.  Impaired erectile function in CD73-deficient mice with reduced endogenous penile adenosine production.

Authors:  Jiaming Wen; Yingbo Dai; Yujin Zhang; Weiru Zhang; Rodney E Kellems; Yang Xia
Journal:  J Sex Med       Date:  2011-05-19       Impact factor: 3.802

Review 7.  The role of adenosine signaling in sickle cell therapeutics.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

8.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

9.  Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism.

Authors:  Jiaming Wen; Xianzhen Jiang; Yingbo Dai; Yujin Zhang; Yuxin Tang; Hong Sun; Tiejuan Mi; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

10.  Effect of ischaemic brain injury on sexual function in adult mice.

Authors:  Yaohui Tang; Falei Yuan; Beibei Cai; Weiliang Xia; Yongting Wang; Guo-Yuan Yang
Journal:  Stroke Vasc Neurol       Date:  2016-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.